Thank you for submitting your manuscript for consideration by The EMBO Journal. It has now been seen by three referees whose comments to the authors are shown below. As you will see while referee 2 is clearly more critical and raises concerns regarding the strength and conclusiveness of the data the other two referees are very positive in principle and would support publication of the study here after appropriate revision. Taking together all issues raised by the referees we have come to the conclusion that we should be able to consider a revised version of this manuscript in which you need to address the referees' concerns in an adequate manner. In particular, it will be important to provide a stronger causal and mechanistic link between the in vitro and the in vivo data and to strengthen the mechanistic part of the study along the lines put forward by referees 1 and 3. Also, the major comment #1 of referee 2 (actin bundling activity of a monomeric molecule) should be addressed/responded to in adequate depth.
I should remind you that it is EMBO Journal policy to allow a single round of revision only and that, therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript as well as on the final assessment by the referees.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
reported that Rng2Ns is monomeric. It is unclear how a monomeric molecule with one actin-binding site could bundle two actin filaments. Additionally, all known actin nucleators contain two or more actin-binding sites, either on one molecule (Spire, Cordon-Bleu) or on separate proteins in a complex or dimer (Arp2/3, formins). What is the proposed mechanism by which such a monomer could bundle or nucleate/elongate actin filaments?
2) It is concluded that Rng2Ns elongates actin filaments (title, throughout paper). The phenotypes of rng2-D5 cells depicted in Figure 1A -F (and in Eng, et al 1998) demonstrates that F-actin is formed and is present in long filaments, suggesting that actin is being efficiently nucleated and elongated at the CR, but improperly coalesced (i.e. bundled). Because bundles of F-actin seem to be fairly long in the mutant and because the authors have not looked at endogenous length of individual F-actin filaments (as was done in Kamasaki, et al 2007) , the title and all claims that Rng2 elongates actin filaments (like "Rng2 is required for... generation of CR F-actin" in the abstract) are unsubstantiated by the data presented. In terms of simply describing the defects in F-actin formation in various strains, it would be helpful if synchronized cultures of cells were examined so that the author's goal of determining when the defect arises could be achieved.
3) In figure 6A , the authors have omitted a positive control, making it difficult to interpret how effective Rng2 is as an actin nucleator compared to other known activators.
4) Many conclusions are drawn from the overproduction studies of Rng2 and various truncations based on what happens to F-actin. However, the effects could be very indirect. As pointed out by the authors, Rng2 has many domains through which it interacts with other proteins besides F-actin. I would not be inclined to conclude so much from this type of experiment. For example, based on Factin localization, it is concluded that Rng2Ns directly interacts with F-actin structures. However, the localization of Rng2Ns is not even shown. Moreover, all of the localization experiments on Rng2 fragments were done in the presence of wild type Rng2, making the results difficult to evaluate if Rng2 is multimeric.
5) It would make for a much better paper if the rationale behind experiments were presented and linked one to the next conceptually, especially in the first part of the paper. 6) If Rng2 counteracts Adf1, then a genetic interaction experiment might substantiate the in vitro studies. Mutation of adf1 should reduce the restrictive temperature of rng2 mutations.
Minor comments:
1) The role of Rng2 is described as "entwining" actin filaments (title) or "entangling" actin filaments (end of introduction). These verbs are inaccurate and misleading, as they suggest that actin at the contractile ring is braided or knotted together, which is not how it appears in ultrastructural studies (Kamasaki, et al 2007) .
2) Analyzing F-actin formation as done in Figure 1 would be more informative if rng2∆ spores were imaged instead of rng2-D5 cells, especially since the mutation in the temperature sensitive allele is C-terminal, outside the domain of focus in this paper and of unknown consequence on the ability of Rng2 to interact with F-actin.
3) The authors emphasize several differences between Rng2CHD and Rng2Ns. It would be helpful if the moiety between amino acids 189 and 300 that is responsible for these differences could be identified. Is it simply a folding issue or is there something else that these residues? 4) Could Rng2N be produced for in vitro studies? Is it a dimer? Does it bundle actin in the same way that Rng2Ns is purported to do? 5) Could immuno-EM be used to show the location of Rng2 fragments in the actin EM? Specifically, it would be important to rule out that the asters in Figure 5F are aggregates of Rng2Ns. 6) Are the bundled actin filaments in Figure 5 parallel or randomly oriented? 7) In the discussion, the authors state that Cdc12 would nucleate actin filaments that would then be elongated by Cdc12 and Rng2 working together. This implies that Rng2 is not nucleating filaments on its own. Is that accurate?
Referee #3 (Remarks to the Author):
This manuscript by Takaine et al examines the role of Rng2p, an IQGAP-related protein, in the assembly of contractile ring during cytokinesis. Rng2p has been shown to play an important role in ring assembly. However, the detailed mechanisms are still unknown. The authors in this study have used both in vitro and in vivo assays to demonstrate that Rng2p is required for actin filament elongation and bundling in the contractile ring. This study provides new insights into the regulation of the process of cytokinesis and merits publication in EMBO.
However the following points should be addressed to improve the quality of the manuscript.
Major Points: 1) The authors use a thermo-sensitive mutant of Rng2 to characterize its phenotype and make observations after shifting the mutants to restrictive temperature for two hours. Not all protein may have been inactivated under these conditions hence the authors should repeat these experiments using null mutant of rng2 (in a germinating spore). Figure 1H , which shows uneven distribution of Rlc1p in the contractile rings of rng2ts mutant, the authors should provide 3D images and tilts of the full rings.
2) For
3) In vitro assay indicates the role of Rng2 in F-actin elongation and crosslinking, which leads to the idea that rng2 can bundles F-actin in actomyosin ring. However, overexpression Rng2 or Rng2Ns leads to the thicker actin filament, which looks like interphase actin cable in Figure 2B , running alone the long axis of the cells. Hence, it seems possible that Rng2 also bundles interphase actin filaments, and not just CR actin filaments as the authors conclude. The authors should check if Rng2Ns can partially rescue the ring assembly defect in Rng2 mutants (ts and null) would be helpful, since Rng2Ns is sufficient for elongation and crosslinking the actin filaments in vitro. They should also over express this fragment in G2 arrested cells to see if the bundling effect is mitosis and CR specific. 4) In vitro, Rng2Ns is resistant to Adf1-induced actin depolymerization. It would be interesting to test it in vivo by investigating whether partially compromised Rng2 can rescue the ring maintenance defect in Adf1-1 mutant. On similar lines does co-over-expression of both Rng2p and /or Rng2Ns along with Adf1 now restore the contractile rings in these cells. 5) There are many textual and grammatical errors in the paper. These errors should be corrected. I have listed just a few below: (page 3, line 12) the word "specified" should be replaced by determined; (page5, first line) "which compose a loose meshwork" should be replaced by which is composed of a loose meshwork; (page5, second line) "the" should be replaced by this; (page 13, line 14) "loosened" should be replaced by loose; (page 16, line 5) "on" should be replaced by to; in the same sentence "dependently of F-actin" should be replaced by in F-actin dependent manner. Putting the MS through a grammar and spell check program will immediately rectify some of these issues. 6) Rng2DNs expression leads to septa despite the inability to assemble actomyosin rings. I wonder? May be some imaging can clarify how this might be the case.
7) The EM and fluorescent bundling assays are impressive. I would like to also see a non specific control (GST/ BSA...) added to this experiment.
Minor points: 1) Figure1E and 1F, in F-actin staining panel, there are two asterisks in wild-type cells and one arrowhead in rng2 mutant cell, but not be mentioned in main text and figure legend.
2) Page 13, line 10 '(arrowheads in Figure 5A )' should be '(asterisks in Figure 5A )'.
3) Figure 3B , Rng2Ns seems to also localize to nucleus, and this is not discussed in the manuscript. One of the cells has two arrowheads, and is not explained in the manuscript. Reply to editor and referees Independently of the referees' comments, we have changed the original Figures 6 and 7 to grayscale figures, and have shown insets of the original Figure 6A and B as Supplementary Figure S6 . These changes do not alter any information in the original figures and hence do not affect the conclusions of this study.
Reply to referee 1 Response: Unfortunately we failed to produce recombinant Rng2N or Rng2C for an in vitro study, thus we cannot biochemically verify a possible interaction between them. Instead we observed cells cooverexpressing both Rng2N and Rng2C. The effects of Rng2N and Rng2C seemed to be additive: abnormal F-actin bundles were produced in elongated mononucleate cells. We have added the new result in the renumbered Figure S3B and described it in the revised Supplementary Results and Discussion (p. 6, lines 8-11) as we had to adhere to the length limit of The EMBO Journal. In addition, we have observed that overexpression of Rng2GRD (Ras GTPase-activating protein (GAP)-related domain, residues 804-1205) or Rng2RasGAP-C (RasGAP-C homology domain, residues 1168-1489) caused no growth or morphological defect, and have described the results in the revised manuscript (p. 10, lines 4-6). These results suggest that the C-terminal domain of Rng2 is unlikely to block the effect of the N-terminal domain of (endogenous or overexpressed) Rng2.
On the other hand, the effect of Rng2C moiety was suppressed upon overexpression of Rng2 (p. 3, lines 2-4 of the original Supplementary Results and Discussion, which corresponds to p. 6, line 11-12 of the revised version). Moreover, Rng2 localizes at SPB during interphase, probably via the Rng2C moiety and is distributed to both the contractile ring and SPBs at mitosis whereas Rng2C alone stays at SPB(s) (Eng et al., Current Biology, 8, 611-621 (1998) ; the original Figure S1A , which is renumbered as Figure S5A in the revised manuscript). Thus, it is probable that the effect or the affinity for SPB of the C-terminal moiety is regulated via the N-terminal moiety in the fulllength protein. Due to the length limit of The EMBO Journal, we have described the above arguments in the revised Supplementary Results and Discussion (p. 6, .
This issue is also related to comment #2, and therefore we have described the function of Rng2Ns moiety in vivo in the Response to comment #2. We showed that Rng2deltaNs (Rng2 lacking Rng2Ns moiety) failed to restore the cytokinesis defect of temperature-sensitive rng2 mutant (rng2ts) strain (the original Figure S3C -E, which is renumbered as Figure S4C -E in the revised manuscript) and rng2-null mutant strain (renumbered Figure S2D ) though Rng2deltaNs forms medial ring at mitosis (Figure 3 ). These results indicate that the Rng2Ns moiety is required for the function of Rng2 in cytokinesis. As Rng2Ns bundles F-actin ( Figure 2B and Figure 5 ), localizes to the contractile ring (CR) F-actin (Figure 3B and G) , and Rng2deltaNs appears not to directly interact with F-actin ( Figure 2D and see also text), it is concluded that F-actin bundling is at least one of the actual functions of Rng2 during cytokinesis. We have described this conclusion more explicitly in the Results (p. 10, line 8-10) and Discussion (p. 21, lines 14-17) of the revised manuscript.
In rng2ts cells, the distribution of Rlc1 (a light chain of myosin II Myo2) in the CR is uneven ( Figure 1H ), and Rng2 genetically interacts with Mid1 (p. 21, line 11 of the original manuscript, which corresponds to p. 25, lines 5-6 of the revised manuscript), which physically anchors Myo2 (a type II myosin of fission yeast) at the medial cortex in late mitosis (Motegi et al., Journal of Cell Biology, 165, 685-695 (2004) ). Thus, we concluded that Rng2 would be involved in the uniform distribution of Myo2 in the CR ( Figure 8B and text) . In addition, we recently found that Rlc1-GFP or YFP-Myo2 is not observed as a medial band of nodes in rng2ts cells (our unpublished data). We therefore speculate that Rng2 may be involved also in Myo2-Mid1 interaction or localization of Myo2 to the nodes. Perturbed distribution of Rlc1 on the CR might be the consequence of a defect in the formation of Myo2 nodes in rng2ts cells. We have described these possibilities in the Discussion of the revised manuscript (p. 25, lines 5-9) and have added Motegi et al. (2004) in the References of the revised manuscript.
On similar lines, it is also possible that Rng2 regulates the localization of Cdc12 to the nodes since Rng2 genetically interacts with formin Cdc12 (Eng et al., Current Biology, 8, 611-621 (1998) ), and Cdc12 can localize to the medial band of nodes at mitosis (Wu et al., Journal of Cell Biology, 174, 391-402 (2006) ). However, localization of Cdc12 in rng2ts cells remains unknown and hence we refrained from mentioning the possibility in the manuscript.
Comment #3:
How is the Rng2-Mid1 interaction relaxed to leave Mid1 away and let Rng2 associate with the ring?
Response: If interactions of Rng2 with F-actin and Mid1 (or nodes) are mutually exclusive, as CR assembles, Rng2 may simply transfer from nodes onto the ring gradually via Rng2Ns moiety that specifically interacts with CR actin filaments. In a case where Rng2 can potentially interact with F-actin and Mid1 (or nodes) at the same time, active regulation seems to be necessary to release Rng2 from nodes. Interaction of Myo2 with Mid1 is temporally regulated by the phosphorylation of Myo2 (Motegi et al., 2004) . Thus, the Rng2-Mid1 interaction also might be regulated by the phosphorylation of Rng2. We have mentioned these possibilities in the Discussion of the revised manuscript (p. 20, line 16 to p. 21, line 4 Referee 2 may suppose that Rng2Ns (or Rng2CHD) has one actin-binding domain (ABD) since it has only one calponin homology domain. However, some actin binding proteins possessing only a single calponin homology domain are reported to contain more than two ABDs. For example, calponin, consisting of 300 amino acids just like Rng2Ns, has one calponin homology domain in the N-terminal half and contains additional ABDs in the C-terminal half, and hence it can bundle Factin (Wu and Jin, Cell Biochem Biophys 52, 139-148 (2008) ). We have summarized the domain organizations and effects of Rng2Ns, Rng2CHD and Rng2Ns-C (residues 190-300) to actin in Supplementary Figure S8 and have stated it in the revised manuscript (p. 24, lines 5-6). We note that Rng2CHD (residues 1-189) or Rng2Ns (residues 1-300) contains an exact calponin homology domain (residues 42-148) and flanking residues (residues 1-41 and residues 149-189 or 149-300) ( Figure S8 ). Therefore, it is very likely that Rng2CHD and Rng2Ns also contain additional ABDs outside the calponin homology domain and hence they contain more than two actin binding sites. Moreover, in vitro assays confirmed the ability of Rng2Ns or Rng2CHD to bundle F-actin, which evidently demonstrates that they can contact with at least two different actin filaments and hence they contain more than two actin-binding sites.
The following discussion assumes that each ABD of Rng2Ns or Rng2CHD contains only one actin binding site for simplicity.
We now speculate that Rng2Ns binds to the side of an actin oligomer (or a filament) via at least a pair of ABDs. Rng2Ns may stabilize the oligomer working as a clamp that binds its subunits together, and hence facilitates the formation of actin nuclei. A similar mechanism was proposed for the function of Salmonella invasion protein A (Sip A) (Lilic et al., Science, 301, 1918 -1921 (2003 ): a fragment of Sip A (residues 497-669) contains two ABDs and stabilizes an actin filament by tethering actin subunits in opposing strands and hence promotes actin polymerization. Rng2CHD, Rng2Ns lacking residues 190-300, can bundle F-actin but fails to promote actin polymerization. We therefore speculate that these residues are required for the stable side-binding of Rng2Ns to actin oligomers but not for bundling of F-actin. Moieties responsible for each ABD will be determined in future studies. We have described the above arguments in the Discussion of the revised manuscript (p. 24, lines 5-17). Accordingly, we have added three papers (Nakano et al., 2005; Wu and Jin, 2008; Lilic et al., 2003) in the References of the revised manuscript.
This issue is also related to minor comment #3 and hence we have also discussed the function of Rng2Ns-C moiety (residues 190-300) and its impact on the actin-binding property of Rng2Ns in the Response to the comment. Figure 1A -F (and in Eng, et al 1998) Kamasaki, et al 2007) , the title and all claims that Rng2 elongates actin filaments (like "Rng2 is required for... generation of CR F-actin" in the abstract) are unsubstantiated by the data presented. In terms of simply describing the defects in F-actin formation in various strains, it would be helpful if synchronized cultures of cells were examined so that the author's goal of determining when the defect arises could be achieved.
Comment #2: It is concluded that Rng2Ns elongates actin filaments (title, throughout paper). The phenotypes of rng2-D5 cells depicted in

demonstrates that F-actin is formed and is present in long filaments, suggesting that actin is being efficiently nucleated and elongated at the CR, but improperly coalesced (i.e. bundled). Because bundles of F-actin seem to be fairly long in the mutant and because the authors have not looked at endogenous length of individual F-actin filaments (as was done in
Response:
We concluded that the generation of CR F-actin is "suppressed" in rng2-D5 cells (p. 6, line 16 of the original manuscript) from the results shown in Figure 1E -F. However, as referee 2 suggested, the wording is overstated because although 62% of rng2-D5 cells showed no accumulation of CR Factin, 36% showed (abnormal) accumulation of CR F-actin and the correct lengths of these filaments were unknown. Therefore, we have described that the generation of CR F-actin is "delayed" in rng2-D5 cells in the revised manuscript (p. 7, lines 1-2). Accordingly, we have removed "elongates" from the title and have used more appropriate expressions throughout the revised manuscript: "Rng2 is involved in the generation of CR F-actin" instead of "Rng2 is required for... " (p. 1, line 17); "Rng2 is involved not only in the construction of CR but also partially in the elongation of its filaments..." (p.21, line 8); "Rng2 assists the elongation of CR F-actin by Cdc12..." (p. 21, line 12); "Rng2 would play a subsidiary role in elongating CR F-actin to assist Cdc12... " (p. 23, line 8) . This issue is also related to minor comments #2 and #7.
Comment #3:
In figure 6A , the authors have omitted a positive control, making it difficult to interpret how effective Rng2 is as an actin nucleator compared to other known activators.
Response:
We compared actin-nucleation activities of Rng2Ns, Fim1, Rng2CHD with that of fission yeast Arp2/3 complex as a positive control by plotting the time to half-maximal polymerization (t 1/2 ) as a function of these proteins' concentrations in Figure 6D of the revised manuscript. Accordingly, the original Figure 6D is relabeled as Figure 6E in the revised manuscript (p. 17, lines 3-7). The activity of 100 nM Rng2Ns was approximately equal to that of 10 nM Arp2/3 complex activated by NWASp-VCA. As the nucleation activity of formin or Spir becomes equivalent to that of Arp2/3 complex only at 100-times higher concentration (Quinlan et al., Nature, 433, 382-388 (2005) ), Rng2Ns seems to be a stronger nucleator than formin or Spire. We have described these results and the argument in the Results of the revised manuscript (p. 15, lines 16-17; p. 16, lines 11-16) . We also have added the protocols for purification of fission yeast Arp2/3 complex and recombinant NWASp-VCA in the Supplementary Experimental Procedures (p. 4, lines 5-9) and have added two papers (Machesky et al., 1999; Sirotkin et al., 2005) to the Supplementary References. We also have added Quinlan et al. (2005) to the References of the revised manuscript.
Comment #4A: Many conclusions are drawn from the overproduction studies of Rng2 and various truncations based on what happens to F-actin. However, the effects could be very indirect. As pointed out by the authors, Rng2 has many domains through which it interacts with other proteins besides F-actin. I would not be inclined to conclude so much from this type of experiment. For example, based on Factin localization, it is concluded that Rng2Ns directly interacts with F-actin structures. However, the localization of Rng2Ns is not even shown.
Response:
Using overproduction studies, we intended to show that Rng2 fragments containing the Rng2Ns moiety (full-length Rng2, Rng2N and Rng2Ns) can produce, directly or indirectly, abnormal F-actin bundles and that fragments lacking the moiety (Rng2C, Rng2∆Ns) fail to produce such F-actin bundles.
However, as pointed out by referee 2, the descriptions "Rng2∆Ns essentially does not interact with F-actin" (p. 9, first line of the original manuscript), "the N-and C-terminal halves of Rng2 have different functions and that the former can directly interact with F-actin structures through the Rng2Ns moiety" (p. 9, lines 7-8 of the original manuscript) and "Rng2Ns bundles F-actin and nucleates actin polymerization in vivo and in vitro" (p. 19, lines 10-11 of the original manuscript) are not substantiated by the data in Figure 2 . We therefore have changed these descriptions in the revised manuscript as follows: "Rng2∆Ns essentially does not interfere with interphase F-actin structures" (p. 9, lines 15-16); "the N-and C-terminal halves of Rng2 have different functions and that the former can produce thick F-actin bundles through the Rng2Ns moiety" (p. 10, lines 7-8); "Rng2Ns bundles F-actin and nucleates actin polymerization in vitro" (p. 21, lines 10-11).
These changes do not affect the conclusion that Rng2 bundles CR F-actin via the Rng2Ns moiety for following reasons: (1) F-actin bundling activity of Rng2Ns is confirmed by in vitro assays; (2) GFP-Rng2Ns localize to the CR in an F-actin-dependent manner; (3) Overexpression of Rng2 or Rng2Ns, but not Rng2∆Ns, produces F-actin bundles, suggesting that even if the Rng2∆Ns moiety can also bundle F-actin, the Rng2Ns moiety has a much greater impact on F-actin bundling function of Rng2. We will simultaneously observe localizations of (endogenous or overexpressed) Rng2 or Rng2Ns and the CR F-actin, including its progenitor and intermediate, in full detail in an upcoming paper. 
Rng2 is essential for the formation of CR, and among several Rng2 fragments only wild-type fulllength Rng2 is able to restore the cytokinesis defect of rng2ts and rng2-null mutant cells (renumbered Figure S4C -E and renumbered Figure S2D ; see also Supplementary Results and Discussion), which indicates that the entire region of Rng2 is required for CR formation. Thus, we inevitably had to observe localizations (to the CR) of "nonfunctional" Rng2 fragments in the presence of wild-type Rng2.
Referee 2 may be concerned that endogenous (wild-type) Rng2 can interact with exogenously expressed Rng2 fragments and hence affects their localizations. However, several Rng2 fragments diffuse in cytoplasm or localize where wild-type Rng2 never or hardly localizes (i.e., actin patches and cables, or SPB), suggesting that their localizations are not confined by endogenous Rng2.
Rng2Ns and some fragments localize on CR and disappear in the presence of Latrunculin-A (i.e., in the absence of F-actin) whereas wild-type Rng2 remains in the medial band of dots even in the absence of F-actin (Figure 3 ). These fragments therefore seem not to interact with endogenous Rng2 but to be tethered to CR F-actin via their own F-actin-binding domains.
Among the Rng2 constructs, localization of Rng2∆Ns is very similar to that of wild-type Rng2. However, even when Rng2∆Ns is richly expressed it never localizes to SPB where endogenous Rng2 is present (data not shown) and hence we suppose that it does not interact with endogenous Rng2.
Moreover, in the localization experiments there should have been excess amounts of exogenous Rng2 fragments against endogenous Rng2 as all the constructs were expressed from multicopy plasmid pREP1. Thus, even if endogenous Rng2 multimerized with these Rng2 fragments, the effect of multimerization on their localizations may not be serious by virtue of their abundant presence.
Comment #5:
It would make for a much better paper if the rationale behind experiments were presented and linked one to the next conceptually, especially in the first part of the paper.
Response:
We have described the aim and design of this study at the end of the Introduction of the revised manuscript (p. 5, lines 9-15). 
We have reexamined the growth of rng2 adf1 double-mutant cells (rng2-D5 adf1-1 and rng2-D5 adf1-KMC; Nakano and Mabuchi, Molecular Biology of the Cell, 17, 1933 Cell, 17, -1945 Cell, 17, (2006 ) at 25, 30, 33 and 36∞C. The new results are shown in Figure S7 . We have found that both double-mutant cells showed a reduced restrictive temperature, as referee 2 suggested. We have described these results in the Results of the revised manuscript (p. 17, line 17 to p. 18, first line). The genetic interaction supports the idea that Rng2 and Adf1 cooperatively regulate F-actin dynamics in CR ( Figure 8B ), and we have stated this in the Discussion of the revised manuscript (p. 22, lines 10-11).
Minor Comment #1:
The role of Rng2 is described as "entwining" actin filaments (title) or "entangling" actin filaments (end of introduction). These verbs are inaccurate and misleading, as they suggest that actin at the contractile ring is braided or knotted together, which is not how it appears in ultrastructural studies (Kamasaki, et al 2007) .
Response:
We agree with referee 2. We have used "arranges" instead of "entwines" in the revised title, and used "mesh-like" instead of "entangled" in the revised manuscript (p. 4, line 10). Table S2 .
We have observed the actin cytoskeleton of wild-type and rng2-null cells, and the new results are shown in renumbered Figure S2 . In cells derived from wild-type spores, a medial F-actin ring was formed at mitosis, and these cells were divided into two, which resulted in normal cell proliferation ( Figure S2A ). In contrast, CR was not formed and instead a large spot of F-actin was formed in rng2-null cells after germination of spores ( Figure S2B ). In these cells, cytokinesis and septation were blocked, whereas polar growth and mitosis were not affected, which eventually made them elongated and multinucleate cells. The F-actin spot was formed at first mitosis in the medial region (i.e., where CR would have formed in wild-type cells) and remained there. We have described these results in the Results of the revised manuscript (p. 7, lines 12-17).
The aforementioned phenotypes of the rng2-null mutant are consistent with those described in the previous study (Eng et al., Current Biology, 8, 611-621 (1998) ), and those of the rng2ts mutant in the sense that CR is not formed. In rng2ts cells at restrictive temperature, at every mitosis F-actin accumulates between segregating nuclei and then disassembles before the onset of the next mitosis ( Figure 1A and Figure S2C) . CR formation appears to be impaired more severely in rng2-null cells since fibrous actin structures do not accumulate where CR should be formed while the F-actin spot is formed only once in the medial region at first mitosis (compare Figure S2B and C) . These results might support our claim that Rng2 is involved in the generation of CR F-actin and suggest that not all Rng2 are inactivated in rng2ts cells at restrictive temperature as referee 3 suggested in major comment #1. We have described these arguments in the Discussion of the revised manuscript (p. 22, lines 5-8).
While the concrete entity of the F-actin spot remains unknown, we suppose it to be a form of abnormally aborted CR F-actin rather than a precursor of CR from which Rng2 would assemble an F-actin ring, as suggested by Eng et al. We speculate that a small portion of Rng2 protein (or mRNA) is carried over to rng2-null spores from maternal diploid cells and the residual activity of Rng2 manages to form an F-actin spot but not CR F-actin at first mitosis. At the second or further mitosis, the F-actin spot is no longer formed due to the short supply of Rng2. Future studies will address the role of the F-actin spot in wild-type cells (vegetative cells and spores).
Minor Comment #3:
The authors emphasize several differences between Rng2CHD and Rng2Ns. It would be helpful if the moiety between amino acids 189 and 300 that is responsible for these differences could be identified. Is it simply a folding issue or is there something else that these residues?
Response:
As described in the original manuscript (p. 18, lines 1-2 and Figure 3J ) and the Supplementary Results and Discussion (p. 2, line 17), GFP-Rng2Ns-C (residues 190-300) diffuses in the cytoplasm and seems not to mark any F-actin structures. Moreover, we have found that overexpression of Rng2Ns-C caused no growth defect, and recombinant Rng2Ns-C did not interact with F-actin or nucleate actin polymerization. We have described these results in the revised Supplementary Results and Discussion (p. 5, lines 2-4) and Figure S8 . These results suggest that on Rng2Ns molecule (residues 1-300), the Rng2Ns-C moiety alters the binding mode of the Rng2CHD moiety (residues 1-189) for F-actin rather than directly interacting with actin (this possibility has been already described on p. 18, lines 3-5 of the original manuscript). As referee 2 suggested, the conformation (i.e., folding) of the Rng2CHD moiety would be changed by the presence of the Rng2Ns-C moiety. As described in the Supplementary Results and Discussion, the triple alanine substitution of residues 242-244 disrupted the function of Rng2 in cytokinesis (original Figure S3 , which is renumbered as Figure S4 in the revised manuscript), and recombinant Rng2Ns bearing the mutation became insoluble under natural conditions. These results also indicate that the Rng2Ns-C moiety contributes to correct folding of Rng2Ns, which assures its stability and solubility. Unfortunately we have failed to produce recombinant Rng2N (residues 1-803) for in vitro study, thus we cannot biochemically verify whether it forms a dimer. We supposed that Rng2 would not dimerize as Rng2 lacks four coiled-coil regions behind the CHD, which is reported to be required for dimerization (Fukata et al., J Biol Chem, 272, 29579-29583 (1997) ) (p. 7, lines 13-14 of the original manuscript and Figure 2A) . However, one coiled-coil region (residues 739-759) exists near the end of Rng2N and we have recently found a paper reporting that IQGAP1 can self-assemble via residues 763-863 (not via the four coiled-coil regions) that corresponds to residues 613-713 of Rng2 (Ren et al., J Biol Chem, 280, 34548-34557 (2005) ). Therefore, we cannot rule out the possibility that Rng2N or Rng2 forms a dimer and crosslink actin filaments with longer arms, and produces looser F-actin bundles than those produced by Rng2Ns. However, as Rng2Ns is sufficient for bundling F-actin and localization to CR F-actin, we believe that at least unitary bundling of CR Factin is mediated by the Rng2Ns moiety.
Minor Comment #5:
Could immuno-EM be used to show the location of Rng2 fragments in the actin EM? Specifically, it would be important to rule out that the asters in Figure 5F are aggregates of Rng2Ns.
Response:
Unfortunately, we have not obtained an appropriate antibody for immuno-EM of Rng2Ns/actin bundles yet; however, since stock solutions of actin-binding proteins (including Rng2Ns) were precleared by centrifugation at 200,000 ×g for 10 min before use (especially after thawing or long storage on ice), the asters in Figure 5F are unlikely to arise from aggregates of Rng2Ns. We have mentioned preclearance in Materials and Methods of the revised manuscript (p. 29, lines 11-13).
Similar aster-like F-actin structures were also observed in a reconstitution system in the presence of both activated Arp2/3 complex and fascin (an F-actin bundling protein) (Ideses et al., PLoS ONE, 3, e3297 (2008)). It should be noted that in this system the aster-like structures spontaneously selfassemble without cores of artificially aggregated Arp2/3 activator or fascin (e. g., microbeads coated with N-WASp-VCA or with fascin). Therefore, it seems reasonable that aster cores also selfassemble from a homogenous mixture of actin and Rng2Ns in the absence of aggregates of Rng2Ns.
We speculate that these asters derive from clusters of short actin filaments crosslinked by Rng2Ns. Since actin filaments are flexible, the ends of crosslinked filaments could point in any direction unless they are completely packed into bundles (i.e., when they are partially crosslinked). Growth of filaments from these radiate ends and subsequent bundling of emanating filaments could form an aster-like structure. We have stated this possibility in the Discussion of the revised manuscript (p. 27, lines 1-4). Accordingly, we have added Ideses et al. (2008) in the References of the revised manuscript.
Minor Comment #6:
Are the bundled actin filaments in Figure 5 parallel or randomly oriented?
Response:
We are also interested in this point. Indeed, we tried to determine the polarities of filaments in Rng2Ns/actin or Fim1/actin bundles by heavy meromyosin (HMM) decoration experiments, but we failed to obtain conclusive data. We feel that these bundles are so tight (especially Rng2Ns/actin bundles) that the "arrowhead structures", which appear by HMM decoration, of the bundled actin filaments become too obscure to be recognized. However, since the polarity of filaments in Rng2Ns/actin or Fim1/actin bundles is outside the focus of this paper and does not influence the conclusions of this study, we will address this point in detail in a separate paper, probably by a more sophisticated method.
For your information, mammalian fimbrin is reported to induce F-actin bundles in which filaments align with the same polarity (Glenney et al., Journal of Biological Chemistry, 256, 9283-9288 (1981) ).
Minor Comment #7:
In the discussion, the authors state that Cdc12 would nucleate actin filaments that would then be elongated by Cdc12 and Rng2 working together. This implies that Rng2 is not nucleating filaments on its own. Is that accurate?
The polymerization-promoting effect of Rng2Ns is attenuated in the presence of profilin Cdc3 ( Figure 6B ). In contrast, Cdc12-stimulated actin polymerization is enhanced in the presence of Cdc3 (Kovar et al., Journal of Cell Biology, 161, 875-887 (2003) ). Moreover, no accumulation of CR Factin is observed in temperature-sensitive cdc12 mutant cells at the restrictive temperature (Chang et al., Journal of Cell Science, 109, 131-142 (1996) ). Therefore, we suppose that Cdc12 plays a critical role in nucleating and elongating the CR F-actin in vivo (i.e., in the abundant presence of Cdc3) though Rng2 can potentially nucleate actin polymerization via Rng2Ns moiety. On the other hand, elongation of CR F-actin occurs but is delayed in rng2ts mutant cells ( Figure 1E-F) , and hence we have concluded that Rng2 plays a subsidiary role in elongating CR F-actin to assist Cdc12. We have described these arguments more explicitly in the Discussion and legend of Figure 8B of the revised manuscript (p. 23, lines 4-8; p. 39, line 8-10) and in the revised Figure 8B .
Reply to Referee 3
Comments by referee 3. Comment #1:
The authors use a thermo-sensitive mutant of Rng2 to characterize its phenotype and make observations after shifting the mutants to restrictive temperature for two hours. Not all protein may have been inactivated under these conditions hence the authors should repeat these experiments using null mutant of rng2 (in a germinating spore).
Response:
We have constructed a null mutant of rng2 and have added a protocol for deletion of the rng2 gene in the Supplementary Experimental Procedures (p. 2, line 16 to p. 4, line 4) and revised Table S2 .
We have observed the actin cytoskeleton of wild-type and rng2-null cells, and the new results are shown in the renumbered Figure S2 . In cells derived from wild-type spores, a medial F-actin ring was formed at mitosis, and these cells were divided into two, which resulted in normal cell proliferation ( Figure S2A ). In contrast, CR was not formed and instead a large spot of F-actin was formed in rng2-null cells after the germination of spores ( Figure S2B ). In these cells, cytokinesis and septation were blocked, whereas polar growth and mitosis were not affected, which eventually resulted in elongated and multinucleate cells. The F-actin spot was formed at first mitosis in the medial region (i.e., where CR would have formed in wild-type cells) and remained there. We have described these results in the Results of the revised manuscript (p. 7, lines 12-17).
The aforementioned phenotypes of the rng2-null mutant are consistent with those described in the previous study (Eng et al., Current Biology, 8, 611-621 (1998) ), and those of the rng2ts mutant in the sense that CR is not formed. In rng2ts cells at restrictive temperature, at every mitosis F-actin accumulates between segregating nuclei and then disassembles before the onset of the next mitosis ( Figure 1A and Figure S2C) . CR formation appears to be impaired more severely in rng2-null cells since fibrous actin structures do not accumulate where CR should be formed while the F-actin spot is formed only once in the medial region at first mitosis (compare Figure S2B and C) . These results might support our claim that Rng2 is involved in the generation of CR F-actin and suggest that not all Rng2 are inactivated in rng2ts cells at restrictive temperature as referee 3 suggested. We have described these arguments in the Discussion of the revised manuscript (p. 22, lines 5-8) .
While the concrete entity of F-actin spot remains unknown, we suppose it to be a form of the abnormally aborted CR F-actin rather than a precursor of CR from which Rng2 would assemble an F-actin ring, as suggested by Eng et al. We speculate that a small portion of Rng2 protein (or mRNA) is carried over to rng2-null spores from maternal diploid cells and the residual activity of Rng2 manages to form an F-actin spot but not CR F-actin at first mitosis. At the second or further mitosis, the F-actin spot is no longer formed due to the short supply of Rng2. Future studies will address the role of the F-actin spot in wild-type cells (vegetative cells and spores).
Comment #2:
For Figure 1H , which shows uneven distribution of Rlc1p in the contractile rings of rng2ts mutant, the authors should provide 3D images and tilts of the full rings.
Response:
We have observed rings of Rlc1-GFP in living wild-type and rng2ts mutant cells as the fluorescence of Rlc1-GFP in fixed cells is too dim to be consecutively imaged for 3D microscopy.
The new results are shown as renumbered Figure S1 , and an experimental procedure for 3D microscopy has been added in Materials and Methods of the revised manuscript (p. 31, lines 5-7). In wild-type cells, rings of Rlc1-GFP appear to be continuous and of homogenous fluorescence, suggesting that Rlc1 (i.e., myosin II) is evenly distributed in CR. On the other hand, about 50% of Rlc1 rings in rng2ts mutant cells showed uneven fluorescence and were sometimes discontinuous while the other rings seemed to be as normal as those in wild-type cells. In addition, we sometimes observed small aggregate(s) of GFP-fluorescence inside an Rlc1 ring in mutant cells. The new result confirms the data shown in Figure 1H , and has been stated in the Results of the revised manuscript (p. 7, lines 9-11). We will reveal where or how the aggregate of Rlc1-GFP arises in an upcoming paper. Figure 2B, 
Comment #3: Overexpression of Rng2 or Rng2Ns leads to the thicker actin filament, which looks like interphase actin cable in
Response:
As described, but not depicted, in the subsection entitled "F-actin-bundling activity is a prerequisite for the function of Rng2 during cytokinesis" in the original Supplementary Results and Discussion (p. 5, lines 9-10, which corresponds to p. 7, lines 7-11 of the revised version), expressions of Rng2Ns, Rng2N, or Rng2C did not rescue the cytokinesis defect of temperaturesensitive Rng2 mutant cells. We regret that we cannot include this section in the main manuscript due to the length limit of The EMBO Journal. We repeated the rescue experiments using a null mutant of Rng2 and found that these fragments also failed to rescue the null mutant. The new results are shown in renumbered Figure S2D and described in the Results of the revised manuscript (p. 10, lines 8-10). Although Rng2Ns can bundle F-actin and interact with CR F-actin by itself, its activity and localization would have to be spatiotemporally regulated via other moieties of Rng2 for CR assembly.
We also overexpressed Rng2, Rng2N and Rng2Ns in cdc25-22 cells arrested at the G2/M boundary and observed their actin cytoskeletons. The new results are shown as renumbered Figure  S3A . Overexpressions of these constructs induced abnormal thick F-actin bundles also in G2 arrested cells although these phenotypes seemed less evident than those depicted in Figure 2 . In addition, we co-overexpressed both Rng2N and Rng2C and found that these effects seemed to be additive: abnormal F-actin bundles were produced in elongated mononucleate cells (renumbered Figure S3B ). These results suggest that the bundling effects of Rng2, Rng2N and Rng2Ns are not necessarily mitotic and CR specific (i.e., they can interfere with interphase F-actin) when they are overexpressed. On the other hand, the bundling activity of the Rng2Ns moiety of endogenous Rng2 would be suppressed at interphase and be put into effect during mitosis as Rng2 localizes to CR Factin but not to F-actin patches or cables. We have described these arguments in the Results (p.9, lines 5-9) and Discussion of the revised manuscript (p. 22, lines 14-16).
Alternatively, as referee 3 suggested, Rng2 may bundle actin filaments into F-actin cables at interphase. In future studies we will simultaneously observe both actin filaments and endogenous Rng2 in great detail in living cells, which would address referee 3's concern whether Rng2 bundles interphase F-actin.
Comment #4: In vitro, Rng2Ns is resistant to Adf1-induced actin depolymerization. It would be interesting to test it in vivo by investigating whether partially compromised Rng2 can rescue the ring maintenance defect in Adf1-1 mutant. On similar lines does co-over-expression of both Rng2p and /or Rng2Ns along with Adf1 now restore the contractile rings in these cells.
We have reexamined the growth of rng2 adf1 double mutant cells (rng2-D5 adf1-1 and rng2-D5 adf1-KMC; Nakano and Mabuchi, Molecular Biology of the Cell, 17, 1933 Cell, 17, -1945 Cell, 17, (2006 ) at 25, 30, 33 and 36ºC and the new results are shown in Figure S7 . Contrary to referee 3's expectations, we found that both double-mutant cells had a reduced restrictive temperature. We have described these results in the Results of the revised manuscript (p. 17, lines 15 to p. 18, first line). The genetic interaction supports the idea that Rng2 and Adf1 cooperatively regulate F-actin dynamics in the CR (Figure 8B ), which is stated in the Discussion of the revised manuscript (p. 22, lines 10-11). We do not suppose a positive genetic interaction between Rng2 and Adf1 to be inconsistent with the result that Rng2Ns act against Adf1-induced F-actin disassembly in vitro. Both active bundling and active disassembly would be important to maintain the dynamics of CR F-actin.
We refrained from co-expressing both Rng2 (or Rng2Ns) and Adf1 in rng2 adf1 double mutants since it is reasonable that double mutants are rescued by expression of the two responsible genes, and we could not gain any new insights into the cooperative effect of Rng2 and Adf1 on CR F-actin from these experiments. Instead we co-overexpressed both Rng2 and Adf1 in wild-type cells and observed their effects on the actin cytoskeleton, and show the new results in the Figures in response to referees. As observed in a previous study (Nakano and Mabuchi, 2006) , overexpression of Adf1 completely disintegrated F-actin structures, including CR F-actin and inhibited cell growth. Simultaneous overexpression of Rng2 or Rng2Ns failed to suppress the effect of Adf1. These results are consistent with those from in vitro assays: Rng2Ns counteracts Adf1-induced F-actin disassembly but does not fully block it. In wild-type cells, expression levels of Rng2 and Adf1 would be properly regulated so as not to disassemble CR F-actin.
Comment #5:
There are many textual and grammatical errors in the paper. These errors should be corrected. I have listed just a few below… Putting the MS through a grammar and spell check program will immediately rectify some of these issues.
Response:
We agree with referee 3. We have corrected these errors according to your suggestions (p. 3, line 14; p. 5, first line; p. 5, second line; p. 14, line 16; p. 17, lines 16-15) in the revised manuscript. Moreover, we have checked the manuscript using a grammar and spell check program and by eye carefully three times.
Comment #6:
Rng2DNs expression leads to septa despite the inability to assemble actomyosin rings. I wonder? May be some imaging can clarify how this might be the case.
Response:
When Rng2deltaNs was overexpressed, we often found cells with a partial and distorted septum (as shown in the Figures in response to referees) in addition to cells with (at least seemingly) a complete septum ( Figure 2D ). Considering that F-actin accumulated at one site in the medial cortex of cells overexpressing Rng2deltaNs (a and c in Figure 2D ), septation may occur from the site. Asymmetrical septation would result in a distorted septum or complete septum in a stochastic manner. It is also concluded that the septation initiation network (SIN) can become active even in the absence of a complete contractile ring, which is not inconsistent with a recent report that SIN independently supports CR assembly (Huang et al., Journal of Cell Biology, 183, 979-988 (2008) ). The complete CR would be required for secure symmetrical septation and separation of daughter cells. We have refrained from discussing this issue in the revised manuscript since it is beyond the purpose of this study.
On the other hand, we felt that we should state that in cells overexpressing Rng2deltaNs, septation occurs but fails to be completed more explicitly in the revised manuscript. Therefore, we have changed "and septation occurred without separation of the cells" (p. 8, line 16 of the original manuscript) to "and cells failed to complete septation" (p. 9, line 13 of the revised manuscript). We also have deleted "septation or" from "did not disturb septation or mitosis" (p. 8, lines 13-14 of the original manuscript, which corresponds to p. 9, lines 10-11 of the revised manuscript) to eliminate confusion.
Comment #7:
The EM and fluorescent bundling assays are impressive. I would like to also see a non specific control (GST/ BSA...) added to this experiment.
Response:
We have repeated the experiments described in Figure 5A- 
We have explained these marks in the legend of Figure 1 and mentioned them in the Results (p. 6, lines 16-17) of the revised manuscript.
Minor Comment #2:
Page 13, line 10 '(arrowheads in Figure 5A )' should be '(asterisks in Figure 5A )'.
Response:
We have corrected the wording according to this suggestion in the revised manuscript (p. 14, line 12).
Minor Comment #3: Figure 3B , Rng2Ns seems to also localize to nucleus, and this is not discussed in the manuscript.
One of the cells has two arrowheads, and is not explained in the manuscript.
Response:
Indeed GFP-Rng2Ns often seems to be concentrated in the nucleus to some extent ( Figure 3B and the original Figure S2 , which is renumbered as Figure S9 in the revised manuscript). We suppose that it is because Rng2Ns is apt to be retained in the nucleus for some unknown reason. However, we do not suppose that the localization of Rng2Ns to the nucleus is physiologically relevant because endogenous Rng2 localizes to the contractile ring, SPB, and the medial broad band of nodes (Eng et al., Current Biology, 8, 611-621 (1998); Wu et al., Journal of Cell Biology, 174, 391-402 (2006) ), but not to the nucleus. As we have to adhere to the length limit of the EMBO Journal, we have described this issue in the revised Supplementary Results and Discussion (p. 5 lines 10-14).
We have mentioned that the double arrowheads indicate the contractile ring during contraction in the legend of Figure 3 of the revised manuscript.
Minor Comment #4:
In materials and methods the concentration of DAPI and Hoechst used for the imaging should be indicated.
Response:
We have indicated the concentrations of DAPI and Hoechst 33342 in Materials and Methods of the revised manuscript (p. 31, lines 10-11).
Minor Comment #5: Page 10 Vavylonis et al is not the correct reference. GFP-Rng2 CHD had been constructed and shown to label all F-actin structures by previous studies!
Response:
We have added the appropriate paper (Wachtler et al., Journal of Cell Science, 116, 867-874 (2003) ) in the References and corrected the citation accordingly (p. 11, line 6) in the revised manuscript.
We hope that the revised manuscript is now acceptable for publication in The EMBO Journal and look forward to hearing from you at your earliest convenience. Thank you for sending us your revised manuscript. Our original referees 2 and 3 have now seen it again. While referee 3 now positive about publication of your paper referee 2 is not happy with the revisions made and feels strongly that there are still a number of issues that need to be addressed (see below). Given the more positive vote by referee 3 and the very positive initial vote by referee 1 (who was not available to look at the revision at this time) and having looked at the case ourselves we have come to the conclusion that the paper should be publishable in The EMBO Journal. Still, we also feel that it would be good to address or respond to the criticisms still put forward by referee 2, mainly at the level of presentation and logical flow of the lines of argumentation.
Please let us have a suitably amended manuscript as soon as possible.
Yours sincerely,
Editor
The EMBO Journal
Referee #2 (Remarks to the Author):
This revised paper is even more diffuse than the previous version. Crammed with yet more tangential structure/function details, the really interesting stuff is difficult to appreciate and it is underdeveloped still. I recommended that the authors present a coherent model and they have not. Given the lapses of logical presentation, lack of rationale for experiments, and conclusions that fail to fit all of the data, I am not satisfied with the revision.
1) The authors continue to suggest that Rng2 elongates actin filaments without having the data to support this conclusion. Their data indicate that Rng2 N-terminal domain has the capacity to crosslink and nucleate, but no data is consistent with failed elongation.
2) The most interesting finding of the paper (and I emphasize that it is exciting yet preliminary) is that a N-terminal domain containing the CHD domain both nucleates and crosslinks F-actin, at least in vitro. However, it is very unclear how this might be happening and whether it is relevant in vivo. For example, why are there no F-actin filaments in cdc12 cells if filaments can be nucleated by Rng2? The authors emphasize several differences between Rng2CHD and Rng2Ns. What is the moiety between amino acids 189 and 300 that is responsible for these differences? What is it doing? What happens with the FH1-FH2 domain of Cdc12?
3) The authors sequences the mutation in rng2-D5, find it lies in the GRD motif, show that the mutant protein does not localize or form rings correctly and yet argue that it is the N-terminus that provides these same properties to the full-length protein. The paper is replete with these sorts of conclusions that do not fit all of the data presented.
4) The authors have resisted time lapse imaging which was recommended in the previous review. Therefore, they can draw no conclusions regarding "when" Rng2 is required for any step in ring formation. And, there is no evidence that F-actin elongation is "delayed".
5) The authors might get further in their analysis if they made targeted mutations in the full-length protein designed to inactivate domains rather than relying on truncations.
Minor comments: 1) "Entangle" still exists in the figures. Over-interpretation/mis-wording still exists throughout.
2) Figure 1 has been largely published previously. Recommend removing.
3) Recommend removing Figure 2C and anything to do with Rng2N. 4) Page 3, sentence beginning "it should be underlined . . " needs re-wording. 5) Add new Kovar lab reference on Cdc8. 6) Page 5, "causes" should be replaced with "mechanisms". 7) New references should be included on node components. 
Response:
We had performed various types of experiments according to the comments by referees 1-3 and described these results in the previous manuscript, which inevitably lengthened the manuscript but never impaired its quality and readability.
As described in the response to the comment #2, we focus on the bundling of CR F-actin by Rng2 in this paper, and promotion of actin assembly by Rng2 is not the primary concern of this study and hence it is relatively "underdeveloped".
In the response to the comment #1 by referee2 in the previous review, we had already described a possible model for promotion of actin assembly by Rng2Ns (p. 24, lines 7-14 of the manuscript). This model is fully reasonable, and so simple that we do not have to depict it.
We had already described the aim and design of this study, which includes rationale for experiments, at the end of the Introduction (p. 5, lines 8-16) very concisely but sufficiently. We are fully confident that data and sentences or paragraphs are placed properly in a logical sequence in this paper, and all the conclusions drawn are compatible with the data presented.
Comment #1:
The authors continue to suggest that Rng2 elongates actin filaments without having the data to support this conclusion. Their data indicate that Rng2 N-terminal domain has the capacity to crosslink and nucleate, but no data is consistent with failed elongation.
Response:
We regret that "Rng2 elongates F-actin" was not necessary suitable to express the effect of Rng2Ns on actin assembly. Indeed, we cannot distinguish strictly whether Rng2Ns nucleate actin assembly or elongate F-actin from our in vitro and in vivo data ( Figure 6A and Supplementary Figure S2 ). Therefore, we have replaced "elongation of CR F-actin" with "generation of CR F-actin" (i. e., nucleation and/or elongation of CR F-actin) throughout the revised manuscript (abstract; p. 5, lines 10-11; p. 6, line 2; p. 8, line 1; p. 15, line 14; p. 21, lines 11-14; p. 23, line 10; Figure 8 and its legend). On similar lines, we also have replaced "nucleates actin polymerization" with "promotes actin polymerization" (p. 17, lines 9-10; p. 21, line 13).
On the other hand, to respond to the minor comment #2 by referee 2 and the comment #1 by referee 3 in the previous review, we had constructed a null mutant of rng2 and observed the actin cytoskeleton of wild-type and rng2-null cells, which is shown in Supplementary Figure S2 . In cells derived from rng2-null spores, CR was not formed and instead a large spot of F-actin was formed only once at first mitosis in the medial region (i.e., where CR would have formed in wild-type cells) and remained there. The spot appears not filamentous at all and is distinguishable from improperly accumulated CR F-actin observed in rng2ts cells (compare Supplementary Figure S2B and C). Although the concrete entity of F-actin spot remains unknown, given that CR F-actin does not appear at all in the rng2-null cells (especially at the second and further mitosis), it is very likely that Rng2 is involved in the generation of CR F-actin directly or indirectly. We had already described the argument in the Discussion (p. 22, lines 7-10).
We now suppose the spot to be a form of the abnormally aborted CR F-actin, and speculate that a small portion of Rng2 protein (or mRNA) is carried over to rng2-null spores from maternal diploid cells and the residual activity of Rng2 manages to form an F-actin spot but not CR F-actin at first mitosis. At the second or further mitosis, the F-actin spot is no longer formed probably due to the short supply of Rng2.
Comment #2:
The most interesting finding of the paper (and I Response:
We are grateful that referee 2 appreciates our finding that Rng2Ns can both promote actin assembly and bundle F-actin. To tell the truth, this finding was a by-product of this study that is primarily concerning the bundling of CR F-actin by Rng2. Anyway, we already revealed several biochemical properties of Rng2Ns, and they appear to be enough to address the questions in this comment in adequate depth.
Question 1: Why are there no F-actin filaments in cdc12 cells if filaments can be nucleated by Rng2?
As described above, we suppose that Rng2 is probably involved in the generation of CR F-actin since CR F-actin is absent in rng2-null cells (Supplementary Figure S2) . Given that cdc12 mutant cells also lacks CR F-actin (Chang et al., 1996) , both Cdc12 and Rng2 seem to be required for generation of CR F-actin. We now speculate that CR F-actin is absent in cdc12-112 cells for the following reason: Fission yeast profilin Cdc3 suppresses the activity of Rng2Ns in promotion of actin assembly in a dose-dependent manner ( Figure 6B ). Generally, in vivo there is a large amount of profilin that is comparable to that of actin to suppress spontaneous actin nucleation (reviewed in Pollard et al., 2000) . Given that there is an about 400 times higher amount of actin than Rng2 in fission yeast cells (Wu and Pollard, 2005) , there would also be an excess amount of Cdc3 present against Rng2. Thus, it is very likely that the effect of Rng2 is almost drowned by that of Cdc3 abundantly present and hence actin nuclei for CR F-actin will not be formed without active Cdc12 (i. e., in cdc12-112 cells). Like other formin proteins, Cdc12 can promote actin assembly even in the presence of Cdc3 (Kovar et al., 2003) . Alternatively, it is also possible that Rng2 interacts with and activates Cdc12. However, we prefer to suppose that Rng2 and Cdc12 may not interact with each other for the reason described below (see the response to Question 4).
We speculate that during CR formation, Cdc12 and Cdc3 mediate de novo actin nucleation, and Rng2 stabilizes these nuclei (by bundling them and/or binding to them) protecting them from Adf1-driven disassembly.
Questions 2 and 3: What is the moiety between amino acids 189 and 300 that is responsible for these differences? What is it doing?
Rng2Ns-C (residues 190-300) itself is unlikely to associate with F-actin both in vivo and in vitro ( Figure 3J , Supplementary Results and Discussion, and Supplementary Figure S8) . Thus, on Rng2Ns molecule (residues 1-300), the Rng2Ns-C moiety would alter the conformation of the Rng2CHD moiety (residues 1-189) and modulate its binding mode for F-actin rather than directly interacts with actin, which was already described in the Discussion (p. 19, lines 14-16). We suppose that the entire region of the Rng2Ns-C moiety is necessary for the modulation as no specific proteininteracting module or motif is found in this region.
Question 4: What happens with the FH1-FH2 domain of Cdc12?
Although Rng2 genetically interacts with Cdc12 (Eng et al., 1998) and we suppose the cooperation of Rng2 with Cdc12 in generating CR F-actin, we do not suppose that Rng2 directly interacts with the FH1-FH2 domain of Cdc12 (Cdc12FH1FH2) at least in vivo. Rng2Ns bundles F-actin (Figures 4 and 5) and appears not to cap the ends of actin filaments ( Figure 6E ), and hence we have concluded that Rng2Ns would bind to the sides of filaments. On the other hand, Cdc12FH1FH2 binds preferentially to the barbed ends of F-actin (Kovar et al., 2003) . Therefore, it is very likely that Rng2 and Cdc12 work at different sites of CR F-actin rather than they interact with each other. We have not tested and have no idea whether Rng2Ns interacts with Cdc12FH1FH2 in vitro in the absence or presence of actin.
Comment #3:
The authors sequences the mutation in rng2-D5, find it lies in the GRD motif, show that the mutant protein does not localize or form rings correctly and yet argue that it is the N-terminus that provides these same properties to the full-length protein. The paper is replete with these sorts of conclusions that do not fit all of the data presented.
Response:
We regret that the inadequate arrangement of paragraphs in the subsection entitled "Rng2 contains multiple localization domains" in the Results section (p. 10) would have caused the referee 2's misreading. This subsection contains five paragraphs, and we described the conclusion of the subsection in the last (the fifth) paragraph. However, in the fourth paragraph we described and discussed the properties of temperature-sensitive mutant Rng2, although which is independent of the conclusion described in the last paragraph. Therefore, referee 2 would have found that we improperly drew the conclusion from irrelevant results. To avoid such misreading, we have replaced the fourth paragraph with the fifth paragraph in the revised manuscript (p. 12) and have suitably amended the text concerning the conclusion of the subsection (p. 12, lines 5-8). We have checked the manuscript and confirmed that now paragraphs are arranged properly in every subsection.
Comment #4:
The authors have resisted time lapse imaging which was recommended in the previous review. Therefore, they can draw no conclusions regarding "when" Rng2 is required for any step in ring formation. And, there is no evidence that F-actin elongation is "delayed".
Response:
We are confused by this comment. Time lapse imaging was not recommended at least explicitly in the previous review by referee 2. Anyway, to avoid any confusion and misreading, we have changed "the generation of CR F-actin was delayed in early anaphase compared to wild-type cells" to "the generation of CR F-actin was disturbed in anaphase" (p. 7, line 2 of the revised manuscript). As shown in Figure 1E -F, having long mitotic spindles assures that the cells were in anaphase, and therefore we can conclude that the generation of CR F-actin is disturbed in anaphase in rng2ts cells. We also have replaced "delayed" (p. 23, line 9) with "disturbed".
Comment #5:
The authors might get further in their analysis if they made targeted mutations in the full-length protein designed to inactivate domains rather than relying on truncations.
Response:
At this time, point mutations that inactivate domains of Rng2 or IQGAP1 proteins (especially their type 3 calponin homology domains) are still unknown. Therefore we preferred to embark on truncation analysis of Rng2, which was much more efficient way than inactivating some domain by arbitrary mutagenesis and by trial and error. Future studies will identify point mutations that inactivate the calponin homology domain of IQGAP1 or Rng2 or the Rng2Ns moiety of Rng2, which will provide us more detailed insights into the function of Rng2.
Minor comment #1:
"Entangle" still exists in the figures. Over-interpretation/mis-wording still exists throughout.
Response:
We apologize and have removed "entangled" from Figure 1 .
Minor comment #2: Figure 1 has been largely published previously. Recommend removing.
Response: Although we agree with referee 2 that the data corresponding to a part of Figure 1A was already described in Eng et al. (1998) , other part of Figure 1 has not been published anywhere and we feel that Figure 1A would be helpful in letting the general readers know visually that Rng2 is involved in composition of the CR F-actin. Therefore, we would prefer to keep Figure 1 . Instead, we have reduced the sizes of panels shown in Figure 1A -D to put less emphasis on these panels.
Minor comment #3:
Recommend removing Figure 2C and anything to do with Rng2N.
Response:
In this study, we sometimes compared Rng2 with fimbrin Fim1 as a control actin-bundling protein (Figures 2, 4-7) . Even though they possess calponin homology domains in common, they produce different types of F-actin bundles in vitro (Figures 4-7) . We suppose Figure 2C important to show that the F-actin-bundling modes of Rng2Ns and Fim1 are different also in vivo, which may characterize structures of the CR and F-actin patches (p. 26, line 17 to p. 27, line 2). Therefore, we would prefer to leave the panel intact.
We have removed panels concerning Rng2N from Figure 2B according to the comment and revised the corresponding description (p. 9, line 4). We have not changed Figure 2A as we performed overexpression experiments using Rng2N according to the comments by referees 1 and 3 (Supplementary Figure S3) and therefore a fragment corresponding to Rng2N must be defined.
Minor comment #4:
Page 3, sentence beginning "it should be underlined . . " needs re-wording.
Response:
We have corrected the wording in the revised manuscript (p. 3, lines 12-13).
Minor comment #5:
Add new Kovar lab reference on Cdc8.
